Literature DB >> 17261614

Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients.

Lars Jelsbak1, Helle Krogh Johansen, Anne-Louise Frost, Regitze Thøgersen, Line E Thomsen, Oana Ciofu, Lei Yang, Janus A J Haagensen, Niels Høiby, Søren Molin.   

Abstract

The ability to establish lifelong persistent infections is a fundamental aspect of the interactions between many pathogenic microorganisms and their mammalian hosts. One example is chronic lung infections by the opportunistic pathogen Pseudomonas aeruginosa in cystic fibrosis (CF) patients. This infection process is associated with extensive genetic adaptation and microevolution of the infecting bacteria. Through investigations of P. aeruginosa populations and infection dynamics in a group of CF patients followed at the Danish CF Clinic in Copenhagen, we have identified two distinct and dominant clones that have evolved into highly successful colonizers of CF patient airways. A significant component of the evolutionary success of these two clones has been their efficient transmissibility among the CF patients. The two clones have been present and transmitted among different CF patients for more than 2 decades. Our data also suggest that the P. aeruginosa population structure in the CF patient airways has been influenced by competition between different clones and that the two dominant clones have been particularly competitive within the lungs, which may add to their overall establishment success. In contrast, we show that adaptive traits commonly associated with establishment of chronic P. aeruginosa infections of CF patients, such as transition to the mucoid phenotype and production of virulence factors, play minor roles in the ability of the two dominant clones to spread among patients and cause long-term chronic infections. These findings suggest that hitherto-unrecognized evolutionary pathways may be involved in the development of successful and persistent P. aeruginosa colonizers of CF patient lungs.

Entities:  

Mesh:

Year:  2007        PMID: 17261614      PMCID: PMC1865789          DOI: 10.1128/IAI.01282-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.

Authors:  S S Pedersen; C Koch; N Høiby; K Rosendal
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

2.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

3.  Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  G Taccetti; S Campana; F Festini; M Mascherini; G Döring
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

4.  Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation.

Authors:  C A DeVries; D E Ohman
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

5.  Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis.

Authors:  Nadine Hoffmann; Thomas Bovbjerg Rasmussen; Peter Østrup Jensen; Charlotte Stub; Morten Hentzer; Søren Molin; Oana Ciofu; Michael Givskov; Helle Krogh Johansen; Niels Høiby
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients.

Authors:  G Fluge; B Ojeniyi; N Høiby; A Digranes; O Ciofu; E Hunstad; O C Haanaes; O T Storrøsten
Journal:  Clin Microbiol Infect       Date:  2001-05       Impact factor: 8.067

7.  Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection.

Authors:  J C Boucher; H Yu; M H Mudd; V Deretic
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

8.  Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  G M Nixon; D S Armstrong; R Carzino; J B Carlin; A Olinsky; C F Robertson; K Grimwood
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

9.  Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.

Authors:  H Yu; M Hanes; C E Chrisp; J C Boucher; V Deretic
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

10.  Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

Authors:  K Cheng; R L Smyth; J R Govan; C Doherty; C Winstanley; N Denning; D P Heaf; H van Saene; C A Hart
Journal:  Lancet       Date:  1996-09-07       Impact factor: 79.321

View more
  81 in total

1.  Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.

Authors:  Ashley E Warren; Carla M Boulianne-Larsen; Christine B Chandler; Kami Chiotti; Evgueny Kroll; Scott R Miller; Francois Taddei; Isabelle Sermet-Gaudelus; Agnes Ferroni; Kathleen McInnerney; Michael J Franklin; Frank Rosenzweig
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Evolutionary dynamics of bacteria in a human host environment.

Authors:  Lei Yang; Lars Jelsbak; Rasmus Lykke Marvig; Søren Damkiær; Christopher T Workman; Martin Holm Rau; Susse Kirkelund Hansen; Anders Folkesson; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Morten O A Sommer; Søren Molin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 3.  The distributed genome hypothesis as a rubric for understanding evolution in situ during chronic bacterial biofilm infectious processes.

Authors:  Garth D Ehrlich; Azad Ahmed; Josh Earl; N Luisa Hiller; J William Costerton; Paul Stoodley; J Christopher Post; Patrick DeMeo; Fen Ze Hu
Journal:  FEMS Immunol Med Microbiol       Date:  2010-05-28

4.  Long-term social dynamics drive loss of function in pathogenic bacteria.

Authors:  Sandra Breum Andersen; Rasmus Lykke Marvig; Søren Molin; Helle Krogh Johansen; Ashleigh S Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

5.  Bacteriocin-mediated competition in cystic fibrosis lung infections.

Authors:  Melanie Ghoul; Stuart A West; Helle Krogh Johansen; Søren Molin; Odile B Harrison; Martin C J Maiden; Lars Jelsbak; John B Bruce; Ashleigh S Griffin
Journal:  Proc Biol Sci       Date:  2015-09-07       Impact factor: 5.349

6.  Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study.

Authors:  Caroline Deppisch; Gloria Herrmann; Ute Graepler-Mainka; Hubertus Wirtz; Susanne Heyder; Corinna Engel; Matthias Marschal; Christopher C Miller; Joachim Riethmüller
Journal:  Infection       Date:  2016-02-09       Impact factor: 3.553

Review 7.  Persistent Infection and Long-Term Carriage of Typhoidal and Nontyphoidal Salmonellae.

Authors:  Ohad Gal-Mor
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

8.  Evolutionary remodeling of global regulatory networks during long-term bacterial adaptation to human hosts.

Authors:  Søren Damkiær; Lei Yang; Søren Molin; Lars Jelsbak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

9.  In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections.

Authors:  Lei Yang; Janus A J Haagensen; Lars Jelsbak; Helle Krogh Johansen; Claus Sternberg; Niels Høiby; Søren Molin
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

10.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.